GeneDx Holdings Corp (NASDAQ:WGS)’s traded shares stood at 0.78 million during the last session, with the company’s beta value hitting 2.10. At the close of trading, the stock’s price was $77.20, to imply a decrease of -2.09% or -$1.65 in intraday trading. The WGS share’s 52-week high remains $89.11, putting it -15.43% down since that peak but still an impressive 98.12% since price per share fell to its 52-week low of $1.45. The company has a valuation of $2.12B, with an average of 0.52 million shares in intraday trading volume over the past 10 days and average of 599.52K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for GeneDx Holdings Corp (WGS), translating to a mean rating of 2.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give WGS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GeneDx Holdings Corp (NASDAQ:WGS) trade information
After registering a -2.09% downside in the last session, GeneDx Holdings Corp (WGS) has traded red over the past five days. The 5-day price performance for the stock is -1.52%, and 1.65% over 30 days. With these gigs, the year-to-date price performance is 2707.27%. Short interest in GeneDx Holdings Corp (NASDAQ:WGS) saw shorts transact 2.34 million shares and set a 3.2 days time to cover.
The extremes give us $34 and $70 for target low and target high price respectively. As such, WGS has been trading 9.33% off suggested target high and 55.96% from its likely low.
GeneDx Holdings Corp (WGS) estimates and forecasts
Looking at statistics comparing GeneDx Holdings Corp share performance against respective industry, we note that the company has outperformed competitors. GeneDx Holdings Corp (WGS) shares are 208.68% up over the last 6 months, with its year-to-date growth rate higher than industry average at 95.38% against 7.70%. The rating firms project that company’s revenue will grow 42.27% compared to the previous financial year.
Revenue forecast for the current quarter as set by 6 analysts is 80.22M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 77.8M.Earnings reports from the last fiscal year show that sales brought in 57.42M and 62.42M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 39.72% before jumping 24.63% in the following quarter.
WGS Dividends
GeneDx Holdings Corp has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
GeneDx Holdings Corp (NASDAQ:WGS)’s Major holders
GeneDx Holdings Corp insiders hold 18.13% of total outstanding shares, with institutional holders owning 70.36% of the shares at 85.94% float percentage. In total, 70.36% institutions holds shares in the company, led by CASDIN CAPITAL, LLC. As of 2024-06-30, the company held over 3.53 million shares (or 13.2482% of shares), all amounting to roughly $92.18 million.
The next major institution holding the largest number of shares is CORVEX MANAGEMENT LP with 2.47 million shares, or about 9.2937% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $64.66 million.
